News

New Creutzfeldt-Jakob disease tests have high sensitivities, specificities

View on the News

An important step in detection

These findings are encouraging because clinicians and researchers have long sought a sensitive and minimally invasive diagnostic tool specifically targeted to the protein that causes all forms of CJD, said Dr. Colin L. Masters.

It will, however, be important for additional studies to determine more precise estimates of the tests’ specificities – necessitated by the wide confidence intervals reported for the tests’ specificities – because the techniques used can give rise to "breakthrough" false-positive results. "Creutzfeldt-Jakob disease is extremely uncommon, and a test without near-perfect specificity may also result in many false positive results if it is applied to patients with a low probability of having the disease. In these circumstances, it is important to highlight the preliminary nature of these studies," Dr. Masters wrote.

Moreover, the finding that abnormal prion protein "seeds" are found in the olfactory mucosa "at concentrations equivalent to those in diseased brain, and several logs greater than those in cerebrospinal fluid," has implications for infection control. "Some experts have [already] recommended appropriate decontamination of surgical instruments that come into contact with the olfactory epithelium of patients at high risk for Creutzfeldt-Jakob disease," he said.

Dr. Master is with the Florey Institute of Neuroscience and Mental Health at the University of Melbourne. These remarks were taken from his editorial accompanying the two reports on CJD assays (N. Engl. J. Med. 2014 August 6 [doi:10.1056/NEJMe1407419]).


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

References

The quantities of the prion protein excreted in the urine were extremely small, so the potential for infectivity was not addressed in this study.

Dr. Orrú’s study was funded by the National Institute of Allergy and Infectious Diseases; Fondazione Cariverona; the Italian Ministry of Health; the Creutzfeldt-Jakob Disease Foundation; Programma Master and Back-Percorsi di rientro; and by donations in memory of Jeffrey Smith from Mary Hilderman Smith, Zoe Smith Jaye, and Jenny Smith Unruh. Dr. Moda’s study was funded by the National Institutes of Health, PrioNet Canada, Merck Serono, the Italian Ministry of Health, Associazione Italiana Encefalopatie da Prioni, Ministero dell’Universita e della Ricerca, the Charles S. Britton Fund, the U.K. Department of Health, and the Scottish government.

Pages

Recommended Reading

VIDEO: Investigative eye amyloid test shines a light on Alzheimer’s pathology
MDedge Family Medicine
Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial
MDedge Family Medicine
VIDEO: Consider cognitive function in elderly before surgery
MDedge Family Medicine
Many dementia patients have guns at home
MDedge Family Medicine
VIDEO: In patients with dementia, ask about guns at home
MDedge Family Medicine
VIDEO: Dementia risk spikes in older veterans with sleep disorders, PTSD
MDedge Family Medicine
VIDEO: Lifestyle improvements prevented cognitive decline in at-risk elderly
MDedge Family Medicine
VIDEO: Late-life hypertension may reduce dementia risk
MDedge Family Medicine
Widowhood paradoxically does not increase risk of dementia in older adults
MDedge Family Medicine
TDP-43 could be potential new biomarker for Alzheimer’s disease
MDedge Family Medicine